Lifeloc Technologies Inc (LCTC)
OTHER OTC:LCTC
Want to see LCTC full AI Analyst Report?
Top Page
Lifeloc Technologies
(OTC:LCTC)
Select Model
Select Model
Rating:52Neutral
Price Target:
$2.00
▼(-11.89% Downside)
Action:Reiterated
Date:06/06/26
The score is primarily constrained by weak financial performance: despite revenue growth and minimal leverage, LCTC is still running meaningful operating and net losses with very negative ROE. Technical indicators are moderately supportive (price above key shorter/intermediate moving averages with positive MACD), and corporate governance news is mildly positive, but valuation remains challenged due to losses and no dividend support.
Positive Factors
Revenue rebound & gross margin
TTM revenue growth of ~18.6% combined with a ~41% gross margin indicates the core product set retains pricing power and demand. Low financial leverage (debt/equity ~0.01) provides durable balance-sheet flexibility to support working capital, consumable replenishment and targeted investment without material debt strain.
Negative Factors
Persistent operating and net losses
Meaningful operating and net losses with deeply negative ROE erode book value and constrain reinvestment. Over a multi-month horizon, continued losses reduce strategic optionality, force prioritization of cash uses, and raise the bar for sustaining R&D, sales expansion, and service infrastructure without new capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue rebound & gross margin
TTM revenue growth of ~18.6% combined with a ~41% gross margin indicates the core product set retains pricing power and demand. Low financial leverage (debt/equity ~0.01) provides durable balance-sheet flexibility to support working capital, consumable replenishment and targeted investment without material debt strain.
Read all positive factors
Lifeloc Technologies (LCTC) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.06M
Dividend YieldN/A
Average Volume (3M)94.00
Price to Earnings (P/E)―
Beta (1Y)0.12
Revenue Growth4.41%
EPS Growth-107.45%
CountryUS
Employees39
SectorTechnology
Sector Strength88
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)-0.85
Shares Outstanding2,752,616
10 Day Avg. Volume100
30 Day Avg. Volume94
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.60
Price to Sales (P/S)0.73
P/FCF Ratio-14.26
Enterprise Value/Market Cap1.20
Enterprise Value/Revenue0.81
Enterprise Value/Gross Profit1.96
Enterprise Value/Ebitda-10.63
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lifeloc Technologies Business Overview & Revenue Model
Company Description
Lifeloc Technologies, Inc. develops, manufactures, and markets portable hand-held and fixed station breathalyzers and related accessories for law enforcement, workplace, corrections, original equipment manufacturing, and consumer markets worldwide...
How the Company Makes Money
Lifeloc primarily makes money by selling alcohol breath-testing devices and by generating recurring revenue from products and services tied to those devices. Key revenue streams include: (1) Hardware sales: revenue from the sale of portable and be...
Lifeloc Technologies Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
63
Positive
Cash Flow
48
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.04M | 9.03M | 8.54M | 9.33M | 8.48M | 7.05M |
| Gross Profit | 3.72M | 3.64M | 3.45M | 4.04M | 3.07M | 3.06M |
| EBITDA | -686.18K | -786.57K | -1.07M | 139.45K | 98.46K | 937.83K |
| Net Income | -2.33M | -2.47M | -1.05M | 205.61K | -455.76K | 675.97K |
Balance Sheet | ||||||
| Total Assets | 6.74M | 6.69M | 8.72M | 8.69M | 8.52M | 8.95M |
| Cash, Cash Equivalents and Short-Term Investments | 569.33K | 746.00K | 1.24M | 1.77M | 2.35M | 2.57M |
| Total Debt | 1.81M | 1.83M | 1.80M | 1.22M | 1.27M | 1.32M |
| Total Liabilities | 2.79M | 2.58M | 2.50M | 2.33M | 2.36M | 2.36M |
| Stockholders Equity | 3.95M | 4.10M | 6.23M | 6.36M | 6.16M | 6.59M |
Cash Flow | ||||||
| Free Cash Flow | -101.25K | -460.77K | -2.02M | -533.96K | -168.25K | -85.53K |
| Operating Cash Flow | 52.13K | 2.02K | -1.33M | -525.74K | 54.33K | 182.94K |
| Investing Cash Flow | -355.61K | -354.38K | -689.45K | -8.21K | -222.58K | -268.48K |
| Financing Cash Flow | -69.19K | 355.95K | 1.49M | -52.18K | -50.66K | 462.13K |
Lifeloc Technologies Technical Analysis
Positive
2.27
Price Trends
2.01
Positive
2.14
Positive
2.55
Negative
Market Momentum
0.08
Negative
58.39
Neutral
56.03
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LCTC, the sentiment is Positive. The current price of 2.27 is above the 20-day moving average (MA) of 2.14, above the 50-day MA of 2.01, and below the 200-day MA of 2.55, indicating a neutral trend. The MACD of 0.08 indicates Negative momentum. The RSI at 58.39 is Neutral, neither overbought nor oversold. The STOCH value of 56.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LCTC.
Lifeloc Technologies Risk Analysis
Lifeloc Technologies disclosed 36 risk factors in its most recent earnings report. Lifeloc Technologies reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Lifeloc Technologies Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | $149.91M | 4,002.93 | 0.15% | ― | 41.39% | ― | |
52 Neutral | $6.06M | -2.60 | -21.03% | ― | 4.41% | -107.45% | |
52 Neutral | $82.69M | -67.36 | -12.20% | ― | 9.64% | 45.26% | |
52 Neutral | $211.84M | ― | -56.90% | ― | 62.35% | -46.70% | |
43 Neutral | $26.15M | -10.53 | -122.90% | ― | -55.89% | -127.24% | |
42 Neutral | $3.14M | -0.27 | -92.69% | ― | 70.99% | 97.04% |
* Technology Sector Average
LCTC
Lifeloc Technologies
2.27
-0.83
-26.77%
REFR
Research Frontiers
0.74
-1.26
-63.10%
CPSH
CPS Technologies
6.72
3.96
143.48%
LINK
Interlink Electronics
4.91
0.92
23.06%
SOBR
SOBR Safe
1.02
-2.65
-72.21%
KULR
KULR Technology Group
3.81
-5.63
-59.64%
Lifeloc Technologies Corporate Events
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Lifeloc Shareholders Back Leadership, Governance Changes at Meeting
Positive
Jun 5, 2026
At its June 3, 2026 Annual Meeting of Shareholders, Lifeloc Technologies reported that 82.7% of its 2,752,616 outstanding common shares were represented, establishing a solid quorum and indicating strong shareholder engagement in its corporate gov...
Business Operations and StrategyPrivate Placements and Financing
Lifeloc Technologies Secures Insider Loan for SpinDetect Development
Neutral
May 8, 2026
On May 4, 2026, Lifeloc Technologies entered into a related-party loan transaction with Chief Financial Officer and Chairman Vern Kornelsen, formalized via a $500,000 promissory note dated May 1, 2026. The company intends to use the proceeds to co...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.